# Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome

> **NCT07328906** · NA · NOT_YET_RECRUITING · sponsor: **University of Belgrade** · enrollment: 174 (estimated)

## Conditions studied

- Postimplantation Syndrome
- Myocardial Injury
- MACE
- Mortality

## Interventions

- **DRUG:** Methylprednisolone (MP)
- **DRUG:** Placebo (saline)

## Key facts

- **NCT ID:** NCT07328906
- **Lead sponsor:** University of Belgrade
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-01
- **Final completion:** 2029-01
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07328906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07328906, "Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07328906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*